{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:37:55Z","timestamp":1793842675973,"version":"4.6.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.exer.2021.108523","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T01:50:54Z","timestamp":1614563454000},"page":"108523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study"],"prefix":"10.1016","volume":"205","author":[{"given":"Alireza","family":"Shoari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan Rezaei","family":"Kanavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Rasaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108523_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jtos.2016.03.003","article-title":"Ocular surface membrane-associated mucins","volume":"14","author":"Ablamowicz","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108523_bib2","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1167\/iovs.13-12235","article-title":"Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis","volume":"54","author":"Acera","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib3","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2147\/CIA.S140912","article-title":"Sex differences in the effect of aging on dry eye disease","volume":"12","author":"Ahn","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.exer.2021.108523_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ICO.0b013e31818d3846","article-title":"Evaluation of patients with dry eye for presence of underlying Sj\u00f6gren\u2019s syndrome","volume":"28","author":"Akpek","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib5","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1167\/iovs.15-17003","article-title":"Role of matrix metalloproteinases 2 and 9 in lacrimal gland disease in animal models of Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Aluri","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ophtha.2013.06.049","article-title":"Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with Stevens-Johnson syndrome and ocular cicatricial pemphigoid","volume":"121","author":"Arafat","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ophtha.2014.07.048","article-title":"Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease","volume":"122","author":"Aragona","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1165\/rcmb.2002-0166TR","article-title":"Matrix metalloproteinase-9 in lung remodeling","volume":"28","author":"Atkinson","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.exer.2021.108523_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138958","article-title":"Clusterin seals the ocular surface barrier in mouse dry eye","volume":"10","author":"Bauskar","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108523_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/ICO.0b013e3181757997","article-title":"Desiccating stress decreases apical corneal epithelial cell size\u2014modulation by the metalloproteinase inhibitor doxycycline","volume":"27","author":"Beardsley","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clae.2015.01.007","article-title":"Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye","volume":"38","author":"Bhargava","year":"2015","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.exer.2021.108523_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jtos.2015.11.006","article-title":"Differential effects of dexamethasone and doxycycline on inflammation and MMP production in murine alkali-burned corneas associated with dry eye","volume":"14","author":"Bian","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108523_bib13","series-title":"Ciclosporin. Karger Publishers","first-page":"9","article-title":"Ciclosporin and its future","author":"Borel","year":"1986"},{"key":"10.1016\/j.exer.2021.108523_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0741-5214(98)70367-2","article-title":"Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease","volume":"27","author":"Boyle","year":"1998","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.exer.2021.108523_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/OPTH.S188314","article-title":"Dry eye disease ranking among common reasons for seeking eye care in a large US claims database","volume":"13","author":"Bradley","year":"2019","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","article-title":"Rethinking dry eye disease: a perspective on clinical implications","volume":"12","author":"Bron","year":"2014","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108523_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.ATV.0000121571.78696.dc","article-title":"Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial","volume":"24","author":"Brown","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exer.2021.108523_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.exer.2021.108523_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pro.2400","article-title":"Architecture and function of metallopeptidase catalytic domains","volume":"23","author":"Cerd\u00e0\u2010Costa","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.exer.2021.108523_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","article-title":"Regulation of matrix metalloproteinases: an overview","volume":"253","author":"Chakraborti","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.exer.2021.108523_bib21","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9570.1000191","article-title":"Biodegradable PLGA-based drug delivery systems for modulating ocular surface disease under experimental murine dry eye","volume":"2","author":"Chang","year":"2011","journal-title":"J. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/09273940903359725","article-title":"Anti-inflammatory activity of azithromycin as measured by its NF-\u043aB inhibitory activity","volume":"18","author":"Cheung","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.exer.2021.108523_bib23","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ophtha.2017.05.031","article-title":"Meibomian gland disease: the role of gland dysfunction in dry eye disease","volume":"124","author":"Chhadva","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib24","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1167\/iovs.08-2476","article-title":"Li de Q, Chen JJ, Bian F, Farley WJ, Pflugfelder SC. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome","volume":"50","author":"Chotikavanich","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sjopt.2013.12.003","article-title":"Recent developments on dry eye disease treatment compounds","volume":"28","author":"Colligris","year":"2014","journal-title":"Saudi J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib26","series-title":"Anales de La Real Academia Nacional de Farmacia. Real Academia Nacional de Farmacia","first-page":"151","article-title":"Dry eye disease compounds currently under evaluation in clinical trials","author":"Colligris","year":"2014"},{"key":"10.1016\/j.exer.2021.108523_bib27","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1167\/iovs.05-1382","article-title":"Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium","volume":"47","author":"Corrales","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2015.07.007","article-title":"Dexamethasone nanowafer as an effective therapy for dry eye disease","volume":"213","author":"Coursey","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.exer.2021.108523_bib29","series-title":"Progress in Molecular Biology and Translational Science. Elsevier","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","author":"Cui","year":"2017"},{"key":"10.1016\/j.exer.2021.108523_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/IIO.0000000000000170","article-title":"Effects of aging in dry eye","volume":"57","author":"de Paiva","year":"2017","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.exer.2021.108523_bib31","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","article-title":"Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline","volume":"47","author":"De Paiva","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108523_bib33","first-page":"1243","article-title":"Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells","volume":"20","author":"Deng","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108523_bib34","first-page":"2015","article-title":"Anti-inflammatory properties of low and high doxycycline doses: an in vitro study","author":"Di Caprio","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.exer.2021.108523_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.exer.2019.03.016","article-title":"Matrix metalloproteinases in keratoconus\u2013Too much of a good thing?","volume":"182","author":"di Martino","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108523_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmed.2018.00033","article-title":"Reflections on dry eye syndrome treatment: therapeutic role of blood products","volume":"5","author":"Drew","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.exer.2021.108523_bib37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcp.21535","article-title":"Role of the hemopexin domain of matrix metalloproteinases in cell migration","volume":"217","author":"Dufour","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.exer.2021.108523_bib38","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cells8090984","article-title":"The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma","volume":"8","author":"Fields","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.exer.2021.108523_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biochi.2008.07.007","article-title":"Role of lactoferrin in the tear film","volume":"91","author":"Flanagan","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.exer.2021.108523_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","article-title":"Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study","volume":"32","author":"Foulks","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1902\/jop.2014.140366","article-title":"Gelatinases and extracellular matrix metalloproteinase inducer are associated with cyclosporin\u2010A\u2010induced attenuation of periodontal degradation in rats","volume":"86","author":"Fu","year":"2015","journal-title":"J. Periodontol."},{"key":"10.1016\/j.exer.2021.108523_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2009.03.003","article-title":"Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice","volume":"8","author":"Gavilanes","year":"2009","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.exer.2021.108523_bib43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/13880209.2020.1787470","article-title":"Current advances of Dendrobium officinale polysaccharides in dermatology: a literature review","volume":"58","author":"Guo","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.exer.2021.108523_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/02713683.2010.490320","article-title":"Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression","volume":"35","author":"G\u00fcrdal","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108523_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/08959374980120010301","article-title":"Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells","volume":"12","author":"Hanemaaijer","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.exer.2021.108523_bib46","first-page":"446","article-title":"Evaluation of treatment for dry eye with 2-hydroxyestradiol using a dry eye rat model","volume":"22","author":"Higuchi","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108523_bib47","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1167\/iovs.15-18383","article-title":"Hyperosmolar tears induce functional and structural alterations of corneal nerves: electrophysiological and anatomical evidence toward neurotoxicity","volume":"56","author":"Hirata","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib48","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/OPX.0000000000000655","article-title":"Omegas and dry eye: more knowledge, more questions","volume":"92","author":"Hom","year":"2015","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib49","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.3390\/s18103249","article-title":"Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances","volume":"18","author":"Huang","year":"2018","journal-title":"Sensors"},{"key":"10.1016\/j.exer.2021.108523_bib50","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ophtha.2012.03.017","article-title":"Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease","volume":"119","author":"Huang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib51","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ajpath.2011.05.036","article-title":"EMMPRIN modulates epithelial barrier function through a MMP\u2013mediated occludin cleavage: implications in dry eye disease","volume":"179","author":"Huet","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108523_bib52","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.21276\/AABS.2017.1402","article-title":"Clusterin: it's implication in health and diseases","volume":"4","author":"Ishaq","year":"2017","journal-title":"Ann Appl Bio-Sciences"},{"key":"10.1016\/j.exer.2021.108523_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.exer.2021.108523_bib54","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ajpath.2012.01.025","article-title":"Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation","volume":"180","author":"Jeong","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108523_bib55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/09168451.2014.910091","article-title":"Pueraria mirifica leaves, an alternative potential isoflavonoid source","volume":"78","author":"Jungsukcharoen","year":"2014","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.exer.2021.108523_bib56","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s13197-012-0677-0","article-title":"Essential fatty acids as functional components of foods-a review","volume":"51","author":"Kaur","year":"2014","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.exer.2021.108523_bib57","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/ICO.0000000000000477","article-title":"Cyclosporine A downregulates MMP-3 and MMP-13 expression in cultured pterygium fibroblasts","volume":"34","author":"Kim","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib58","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","article-title":"Curcumin, an active component of turmeric (Curcuma longa), and its effects on health","volume":"57","author":"Kocaadam","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.exer.2021.108523_bib59","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1167\/iovs.15-17249","article-title":"Improvement of outcome measures of dry eye by a novel integrin antagonist in the murine desiccating stress model","volume":"56","author":"Krauss","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0765.2011.01450.x","article-title":"Cyclosporine\u2010A inhibits MMP\u20102 and\u20109 activities in the presence of Porphyromonas gingivalis lipopolysaccharide: an experiment in human gingival fibroblast and U937 macrophage co\u2010culture","volume":"47","author":"Kuo","year":"2012","journal-title":"J. Periodontal. Res."},{"key":"10.1016\/j.exer.2021.108523_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","article-title":"Nuclear Factor-\u03baB: central regulator in ocular surface inflammation and diseases","volume":"10","author":"Lan","year":"2012","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108523_bib62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtos.2015.12.007","article-title":"Dry eye profiles in patients with a positive elevated surface matrix metalloproteinase 9 point-of-care test versus negative patients","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108523_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","article-title":"The matrix metalloproteinase 9 point-of-care test in dry eye","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108523_bib64","first-page":"1","article-title":"Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2021.108523_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108523_bib66","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1167\/iovs.04-0299","article-title":"Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells","volume":"45","author":"Li","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib67","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1167\/iovs.09-4992","article-title":"Suppressive effects of azithromycin on zymosan-induced production of proinflammatory mediators by human corneal epithelial cells","volume":"51","author":"Li","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib68","first-page":"1981","article-title":"Hyperosmolarity stimulates production of MMP-9, IL-1\u00df and TNF-by human corneal epithelial cells via a c-Jun NH2-terminal kinase pathway","volume":"43","author":"Li","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib69","first-page":"317","article-title":"Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system","volume":"18","author":"Li","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108523_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.sjopt.2014.06.002","article-title":"Dry eye disease: a review of diagnostic approaches and treatments","volume":"28","author":"Lin","year":"2014","journal-title":"Saudi J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib71","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.intimp.2011.08.014","article-title":"Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sj\u00f6gren\u2019s syndrome mice","volume":"11","author":"Lin","year":"2011","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.exer.2021.108523_bib72","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib73","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.18773\/austprescr.2015.030","article-title":"Prescribing azithromycin","volume":"38","author":"McMullan","year":"2015","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.exer.2021.108523_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.001","article-title":"Corneal structure and transparency","volume":"49","author":"Meek","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108523_bib76","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","article-title":"Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay","volume":"123","author":"Messmer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","article-title":"Dysfunctional tear syndrome: dry eye disease and associated tear film disorders\u2013new strategies for diagnosis and treatment","volume":"28","author":"Milner","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-7843.2012.00896.x","article-title":"A highly soluble matrix metalloproteinase\u20109 inhibitor for potential treatment of dry eye syndrome","volume":"111","author":"Mori","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.exer.2021.108523_bib79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/gb-2011-12-11-233","article-title":"Tissue inhibitors of metalloproteinases","volume":"12","author":"Murphy","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.exer.2021.108523_bib80","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2010.07918.x","article-title":"Localizing matrix metalloproteinase activities in the pericellular environment","volume":"278","author":"Murphy","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.exer.2021.108523_bib81","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/ijms18081764","article-title":"Analysis of the pathogenic factors and management of dry eye in ocular surface disorders","volume":"18","author":"Nebbioso","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib82","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10930-017-9727-9","article-title":"Omega-3 and Omega-6 fatty acids act as inhibitors of the matrix metalloproteinase-2 and matrix metalloproteinase-9 activity","volume":"36","author":"Nicolai","year":"2017","journal-title":"Protein J."},{"key":"10.1016\/j.exer.2021.108523_bib83","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/ICO.0000000000000543","article-title":"Effects of quercetin in a mouse model of experimental dry eye","volume":"34","author":"Oh","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib84","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1167\/iovs.06-0809","article-title":"Protective effect of uridine on cornea in a rabbit dry eye model","volume":"48","author":"Oh","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.exer.2021.108523_bib86","first-page":"76","article-title":"Matrix metalloproteinases and cardiovascular diseases","volume":"13","author":"Papazafiropoulou","year":"2009","journal-title":"Hippokratia"},{"key":"10.1016\/j.exer.2021.108523_bib87","first-page":"249","article-title":"Curcumin: therapeutical potential in ophthalmology","volume":"80","author":"Pescosolido","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.exer.2021.108523_bib88","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ajo.2011.08.023","article-title":"Tear dysfunction and the cornea: LXVIII Edward Jackson memorial lecture","volume":"152","author":"Pflugfelder","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib89","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","article-title":"Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-\u03b22 production","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","article-title":"Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye","volume":"166","author":"Pflugfelder","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108523_bib92","first-page":"595","article-title":"A randomized crossover study comparing trehalose\/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome","volume":"11","author":"Pinto-Bonilla","year":"2015","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.exer.2021.108523_bib93","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5114\/ceji.2019.87070","article-title":"Therapeutic potential of curcumin in eye diseases","volume":"44","author":"Radomska-Le\u015bniewska","year":"2019","journal-title":"Cent. J. Immunol."},{"key":"10.1016\/j.exer.2021.108523_bib94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/ICU.0b013e3283477d23","article-title":"Current opinion in ophthalmology nutritional supplements for dry eye syndrome","volume":"22","author":"Rand","year":"2011","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib95","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30318-8","article-title":"Ocular effects of topical and systemic steroids","volume":"10","author":"Renfro","year":"1992","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.exer.2021.108523_bib96","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/OPTH.S113437","article-title":"Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature","volume":"11","author":"Rhee","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib97","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/chem.201504355","article-title":"A divalent PAMAM\u2010based matrix metalloproteinase\/carbonic anhydrase inhibitor for the treatment of dry eye syndrome","volume":"22","author":"Richichi","year":"2016","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.exer.2021.108523_bib98","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.str.2007.07.019","article-title":"Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9\/gelatinase B","volume":"15","author":"Rosenblum","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.exer.2021.108523_bib99","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108523_bib100","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2147\/OPTH.S121256","article-title":"Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye","volume":"10","author":"Sambursky","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib101","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/ICO.0000000000000175","article-title":"Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease","volume":"33","author":"Sambursky","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","article-title":"Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye","volume":"131","author":"Sambursky","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2021.108523_bib103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/02713680903453494","article-title":"The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model","volume":"35","author":"Seo","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108523_bib104","doi-asserted-by":"crossref","first-page":"19699","DOI":"10.1002\/jcb.29276","article-title":"Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase","volume":"120","author":"Shoari","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.exer.2021.108523_bib105","article-title":"In vivo effect of RSH-12, a novel selective MMP-9 inhibitor peptide, in the treatment of experimentally induced dry eye model","volume":"1\u20137","author":"Shoari","year":"2020","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108523_bib106","first-page":"1308","article-title":"Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology","volume":"10","author":"Singh","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib107","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1167\/iovs.04-1368","article-title":"Thymosin-\u03b24 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury","volume":"46","author":"Sosne","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib108","first-page":"201","article-title":"Thymosin beta 4: a novel corneal wound healing and anti-inflammatory agent","volume":"1","author":"Sosne","year":"2007","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108523_bib109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01922409","article-title":"The history of cyclosporin A (Sandimmune\u00ae) revisited: another point of view","volume":"52","author":"St\u00e4helin","year":"1996","journal-title":"Experientia"},{"key":"10.1016\/j.exer.2021.108523_bib110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.ICL.0000161705.19602.C9","article-title":"Effect of experimental dry eye on tear sodium concentration in the mouse","volume":"31","author":"Stewart","year":"2005","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.exer.2021.108523_bib111","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108523_bib112","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbamcr.2009.04.003","article-title":"Matrix metalloproteinases: fold and function of their catalytic domains","volume":"1803","author":"Tallant","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.exer.2021.108523_bib113","first-page":"1","article-title":"Review of biomarkers in ocular matrices: challenges and opportunities","volume":"36","author":"Tamhane","year":"2019","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.exer.2021.108523_bib114","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1167\/iovs.05-1504","article-title":"Tear film osmolarity: determination of a referent for dry eye diagnosis","volume":"47","author":"Tomlinson","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1076\/ceyr.16.2.158.5085","article-title":"Changes in rat corneal matrix metalloproteinases and serine proteinases under vitamin A deficiency","volume":"16","author":"Twining","year":"1997","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108523_bib116","doi-asserted-by":"crossref","first-page":"DES157","DOI":"10.1167\/iovs.17-23756","article-title":"The ocular surface glycocalyx and its alteration in dry eye disease: a review","volume":"59","author":"Uchino","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib117","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1074\/jbc.M115.708438","article-title":"Inhibition of MMP-9-dependent degradation of gelatin, but not other MMP-9 substrates, by the MMP-9 hemopexin domain blades 1 and 4","volume":"291","author":"Ugarte-Berzal","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108523_bib118","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1167\/iovs.11-7627","article-title":"Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests","volume":"53","author":"VanDerMeid","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib119","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","article-title":"The core mechanism of dry eye disease (DED) is inflammation","volume":"40","author":"Wei","year":"2014","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.exer.2021.108523_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113810","article-title":"Diurnal variation of tight junction integrity associates inversely with matrix metalloproteinase expression in Xenopus laevis corneal epithelium: implications for circadian regulation of homeostatic surface cell desquamation","volume":"9","author":"Wiechmann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108523_bib121","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.sjbs.2016.11.016","article-title":"Beneficial effect of daidzin in dry eye rat model through the suppression of inflammation and oxidative stress in the cornea","volume":"25","author":"Xiao","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.exer.2021.108523_bib122","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcp.20948","article-title":"Regulation of matrix metalloproteinase gene expression","volume":"211","author":"Yan","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.exer.2021.108523_bib123","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/cbdd.13529","article-title":"Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization","volume":"95","author":"Zhang","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.exer.2021.108523_bib124","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamaophthalmol.2015.2326","article-title":"Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease","volume":"133","author":"Zhang","year":"2015","journal-title":"JAMA Ophthalmol"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:13:47Z","timestamp":1757999627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":124,"alternative-id":["S0014483521000889"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108523","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108523"}}